The T. Rowe Price Small-Cap Stock strategy’s (which includes the Canadian subadvised vehicle and US separate account) fairly new manager uses a sensible approach, which makes it a compelling option at the right price.
T. Rowe Price Institutional Small-Cap Stock Fund TRSSX
- NAV / 1-Day Return $26.01 / +1.64 %
- Fund Size $4.3B
- Adjusted Expense Ratio 0.660%
- Net Expense Ratio 0.660%
- Fee Level: Distribution Low
- Share Class Type Institutional
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $1M
- Investment Status Open
- TTM Yield 0.29%
- Turnover Ratio 84%
Morningstar’s Analysis TRSSX
Will TRSSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Aggregate Miscellaneous Equity | 4.94 | 211M | — |
Liberty Live Holdings Inc Ordinary Shares (Liberty Live Group) Series C | 2.77 | 118M | Communication Services |
Immunome Inc Ordinary Shares | 2.00 | 85M | Healthcare |
InterDigital Inc | 1.81 | 77M | Technology |
Dyne Therapeutics Inc Ordinary Shares | 1.61 | 68M | Healthcare |
TMX Group Ltd | 1.52 | 65M | Financial Services |
OR Royalties Inc | 1.52 | 65M | Basic Materials |
Lattice Semiconductor Corp | 1.38 | 59M | Technology |
BrightSpring Health Services Inc | 1.35 | 58M | Healthcare |
Dianthus Therapeutics Inc | 1.35 | 58M | Healthcare |